PLAYSTUDIOS, Inc (MYPS) Files a Proposed Offering of up to 119M Shares

Go back to PLAYSTUDIOS, Inc (MYPS) Files a Proposed Offering of up to 119M Shares

Pre-Open Stock Movers 07/16: (GLG) (AEHR) (MGI) Higher; (FGEN) (AOUT) (CRVS) Lower (more...)

July 16, 2021 9:30 AM EDT

Pre-Open Stock Movers

FibroGen, Inc. (NASDAQ: FGEN) 36.2% LOWER; announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted to recommend not approving roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, for the treatment of anemia due to chronic kidney disease (CKD) in adult patients. The Committee based its recommendation on data from a global Phase 3 program encompassing more than 8,000 patients. While the FDA is not... More

After-Hours Stock Movers 07/15: (AEHR) (APT) (MRNA) Higher; (AOUT) (CRVS) Lower (more...)

July 15, 2021 6:22 PM EDT

After-Hours Movers

Aehr Test Systems (NASDAQ: AEHR) 19.6% HIGHER; Net sales were $7.6 million, up 102% from $3.8 million in the fourth quarter of fiscal 2020.

American Outdoor Brands (NASDAQ: AOUT) 11.2% LOWER; reported Q4 EPS of $0.09, $0.14 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $64.5 million versus the consensus estimate of $62.03 million. American Outdoor Brands sees FY2022 EPS of $1.00-$1.24. American... More

UPDATE: Oppenheimer Starts PlayStudios (MYPS) at Outperform, $11 PT

July 15, 2021 4:06 PM EDT

(Updated - July 15, 2021 4:56 PM EDT)

Oppenheimer analyst Martin Yang initiates coverage on PlayStudios (NASDAQ: MYPS) with a Outperform rating and a price target of $11.00.

The analyst commented, "We initiate coverage on PLAYSTUDIOS with an Outperform rating and $11 PT. MYPS'... More